Novel cell lines for the analysis of preprotachykinin A gene expression identify a repressor domain 3′ of the major transcriptional start site

被引:11
作者
Fiskerstrand, CE
Newey, P
Ebrahimi, B
Gerrard, L
Harrison, P
McGregor, GP
Quinn, JP
机构
[1] Univ Edinburgh, Dept Vet Pathol, Edinburgh EH9 1QH, Midlothian, Scotland
[2] Univ Marburg, Inst Physiol, D-35037 Marburg, Germany
基金
英国惠康基金;
关键词
dorsal root ganglion neurons; NF2C cell lines; RIN cells; substance P; tachykinin;
D O I
10.1042/0264-6021:3410847
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Until now, no clonal cells have been identified that support the expression of a marker gene expressed from the rat preprotachykinin A (rPPT) promoter. We have analysed recently available cell lines that are candidates for supporting reporter gene expression directed by the rPPT promoter. These are the neuronal-derived cell line NF2C and the pancreatic cell lines RINm5F and a derivative RIN-1027-B2. The NF2C line was derived from the brain homogenate of a transgenic animal in which a temperature-sensitive simian virus 40 large T antigen was expressed from a neurofilament promoter. All three lines are able to support expression of a reporter gene directed by a fragment of the 5' rPPT promoter. Analysis of reporter gene expression supported by various fragments of the rPPT promoter demonstrated that although -865 to +92 bp supported expression, the addition of fragments between +92 and +447 bp led to repression of expression. Subsequent analysis of reporter gene constructs microinjected into primary cultures of dorsal root ganglion neurons (DRG) confirmed the existence of this repressor domain. This repression could be relieved totally in both RIN cell lines and partly in NF2C cells by mutating residues between +373 and +396 bp. This indicates that these cell lines support PPT promoter activity similar to that observed in DRG and determines a novel repressor domain within the promoter.
引用
收藏
页码:847 / 852
页数:6
相关论文
共 27 条
[1]  
CAMPLING BG, 1995, CANCER, V75, P2442, DOI 10.1002/1097-0142(19950515)75:10<2442::AID-CNCR2820751009>3.0.CO
[2]  
2-Q
[3]  
FABIEN N, 1994, CANCER J - FRANCE, V7, P198
[4]   The molecular biology of preprotachykinin-A gene expression [J].
Fiskerstrand, C ;
Quinn, JP .
NEUROPEPTIDES, 1996, 30 (06) :602-610
[5]   The role of the Octamer binding proteins and the NF-κB complex in neuropeptide gene expression [J].
Fiskerstrand, CF ;
Newey, P ;
Millan, F ;
Quinn, JP .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (04) :S573-S573
[6]   IDENTIFICATION AND CDNA SEQUENCE OF DELTA PREPROTACHYKININ, A 4TH SPLICING VARIANT OF THE RAT SUBSTANCE-P PRECURSOR [J].
HARMAR, AJ ;
HYDE, V ;
CHAPMAN, K .
FEBS LETTERS, 1990, 275 (1-2) :22-24
[7]   DIVERSITY IN MAMMALIAN TACHYKININ PEPTIDERGIC NEURONS - MULTIPLE PEPTIDES, RECEPTORS, AND REGULATORY MECHANISMS [J].
HELKE, CJ ;
KRAUSE, JE ;
MANTYH, PW ;
COUTURE, R ;
BANNON, MJ .
FASEB JOURNAL, 1990, 4 (06) :1606-1615
[8]   SMALL-CELL LUNG-CARCINOMA CELL-LINES EXPRESS MESSENGER-RNA FOR CALCITONIN AND ALPHA-CALCITONIN AND BETA-CALCITONIN GENE-RELATED PEPTIDES [J].
KELLEY, MJ ;
SNIDER, RH ;
BECKER, KL ;
JOHNSON, BE .
CANCER LETTERS, 1994, 81 (01) :19-25
[9]   Osmotic and non-osmotic regulation of arginine vasopressin (AVP) release, mRNA, and promoter activity in small cell lung carcinoma (SCLC) cells [J].
Kim, JK ;
Summer, SN ;
Wood, WM ;
Schrier, RW .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 123 (02) :179-186
[10]  
MAGGIO JE, 1988, ANNU REV NEUROSCI, V11, P13, DOI 10.1146/annurev.neuro.11.1.13